139 related articles for article (PubMed ID: 17414581)
1. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
de Roa ER; Botero R; Octavio JA; Berrizbeitia ML; Mayorca E; Castro P; Miranda R; Valecillo E; Aroca G; Aza G; González M
Am J Ther; 2007; 14(2):140-6. PubMed ID: 17414581
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension.
Fritschka E
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S62-8. PubMed ID: 1283192
[TBL] [Abstract][Full Text] [Related]
3. New sustained-release nifedipine formulation in treatment of essential hypertension. Unidipin Cooperative Study Group.
J Cardiovasc Pharmacol; 1992 Mar; 19(3):349-53. PubMed ID: 1378112
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
Krakoff LR; Bravo EL; Tuck ML; Friedman CP
Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
Welzel D; Burger KJ; Weidinger G
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S70-4. PubMed ID: 1695308
[TBL] [Abstract][Full Text] [Related]
6. First clinical experience with isradipine in the treatment of hypertension in Portugal.
Rocha-Gonçalves F; Mariano-Pego G; Viegas J; Correia JM; Botelho MA
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
[TBL] [Abstract][Full Text] [Related]
7. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
Faust G
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S56-61. PubMed ID: 1283191
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive effectiveness of nifedipine gastrointestinal therapeutic system in the elderly. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
Bravo EL; Krakoff LR; Tuck ML; Friedman CP
Am J Hypertens; 1990 Dec; 3(12 Pt 2):326S-332S. PubMed ID: 2078319
[TBL] [Abstract][Full Text] [Related]
9. Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Fletcher AE; Battersby C; Adnitt P; Underwood N; Jurgensen HJ; Bulpitt CJ
J Cardiovasc Pharmacol; 1992 Jul; 20(1):108-14. PubMed ID: 1383618
[TBL] [Abstract][Full Text] [Related]
10. [On the clinical evaluation of therapy with nifedipine in association with various anithypertensive drugs (author's transl)].
Laaser U; Meurer KA; Kaufmann W
Arzneimittelforschung; 1977; 27(3):676-81. PubMed ID: 577445
[TBL] [Abstract][Full Text] [Related]
11. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients.
Os I; Bratland B; Dahløf B; Gisholt K; Syvertsen JO; Tretli S
J Hypertens; 1991 Dec; 9(12):1097-104. PubMed ID: 1663965
[TBL] [Abstract][Full Text] [Related]
12. The antihypertensive action of isradipine in mild essential hypertension.
Viskoper JR; Laszt A; Farragi D
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S9-11. PubMed ID: 1720488
[TBL] [Abstract][Full Text] [Related]
13. Labetalol and nifedipine in the management of essential hypertension.
Prasad NK
J Indian Med Assoc; 1990 Jul; 88(7):188-9. PubMed ID: 2266262
[TBL] [Abstract][Full Text] [Related]
14. Treatment of isolated systolic hypertension with labetalol in the elderly.
Giles TD; Weber M; Bartels DW; Silberman HM; Gilderman LP; Burris JF
Arch Intern Med; 1990 May; 150(5):974-6. PubMed ID: 2184794
[TBL] [Abstract][Full Text] [Related]
15. Combination of nifedipine and carteolol compared to nifedipine alone in diurnal blood pressure variation and exercise blood pressure in patients with essential hypertension.
Inoue I; Matsuura H; Fujii T; Ishida T; Ozono R; Kainouchi M; Tsuchioka Y; Kajiyama G
Clin Ther; 1992; 14(1):22-9. PubMed ID: 1576623
[TBL] [Abstract][Full Text] [Related]
16. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
[TBL] [Abstract][Full Text] [Related]
17. A parallel group randomised comparative study of felodipine and nifedipine in hypertension.
Sharma SM; Sethi KK; Kaul UA; Arora R; Khalilullah M
Indian Heart J; 1991; 43(3):171-3. PubMed ID: 1800302
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine retard in the treatment of hypertension. A study using ambulatory blood pressure recordings.
Hwang YS
Clin Ther; 1990; 12(6):503-12. PubMed ID: 2289219
[TBL] [Abstract][Full Text] [Related]
19. [Sublingually administered captopril versus nifedipine in hypertension emergencies].
Guerrera G; Melina D; Capaldi L; Mauro R; Colivicchi F; Cardillo C; Guerrera G; Musumeci V; Savi L; Santoliquido A
Minerva Cardioangiol; 1990; 38(1-2):37-44. PubMed ID: 2188165
[TBL] [Abstract][Full Text] [Related]
20. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
Lossnitzer K; Huber HJ; Kuchlbauer R; Quitzdorff G
J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S35-42. PubMed ID: 1283187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
